Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer

Advanced melanoma and non-melanoma skin cancers (NMSCs) are burdened with a dismal prognosis. To improve the survival of these patients, studies on immunotherapy and target therapies in melanoma and NMSCs are rapidly increasing. BRAF and MEK inhibitors improve clinical outcomes, and anti-PD1 therapy...

Full description

Bibliographic Details

Published in:	Frontiers in Medicine
Main Authors:	Marco Rubatto, Nadia Sciamarrelli, Silvia Borriello, Valentina Pala, Luca Mastorino, Luca Tonella, Simone Ribero, Pietro Quaglino
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Subjects:	melanoma non-melanoma skin cancer immunotherapy new drugs targeted therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2022.959289/full